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The innate immune response is precisely gated 
by regulatory mechanisms during both detec-
tion of a threat to the host and also the resulting 
responses. Such control is essential for prevent-
ing inappropriate or prolonged innate immune 
responses, which may damage the host as much 
as the pathogen or damaging signal itself. Spe-
cifically, posttranslational modification of sub-
strate proteins by ubiquitination has been reported 
for many targets in innate immune signaling 
pathways as a mechanism of regulating their 
functions. The diversity of effects on target 
protein degradation, binding partner affinity, or 
localization resulting from ubiquitination mod-
ification is dependent on the lysine linkage po-
sition and length of the ubiquitin chain attached 
by a ubiquitin ligase enzyme. As a central pathway 
downstream from many innate and adaptive im-
mune receptors, the NF-B signaling pathway 
is highly regulated by lysine 48 (K48), K63, and 
linear ubiquitination modifications that are re-
quired for the ultimate release of the p50/p65 
NF-B transcription factor to the nucleus where 
it can turn on the expression of proinflamma-
tory genes (Iwai and Tokunaga, 2009). After re-
ceptor stimulation by CD40 ligand, TNF, or 
IL-1, the cIAP-mediated K63 ubiquitination 
of Rip1 or TRAF6 leads to recruitment of the 
linear ubiquitin assembly complex (LUBAC), 
consisting of HOIP and HOIL-1L or Sharpin, 
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Linear ubiquitination is a newly discovered posttranslational modification that is currently 
restricted to a small number of known protein substrates. The linear ubiquitination assem-
bly complex (LUBAC), consisting of HOIL-1L, HOIP, and Sharpin, has been reported to 
activate NF-B–mediated transcription in response to receptor signaling by ligating linear 
ubiquitin chains to Nemo and Rip1. Despite recent advances, the detailed roles of LUBAC in 
immune cells remain elusive. We demonstrate a novel HOIL-1L function as an essential 
regulator of the activation of the NLRP3/ASC inflammasome in primary bone marrow–
derived macrophages (BMDMs) independently of NF-B activation. Mechanistically, HOIL-
1L is required for assembly of the NLRP3/ASC inflammasome and the linear ubiquitination 
of ASC, which we identify as a novel LUBAC substrate. Consequently, we find that HOIL-
1L/ mice have reduced IL-1 secretion in response to in vivo NLRP3 stimulation and 
survive lethal challenge with LPS. Together, these data demonstrate that linear ubiquitina-
tion is required for NLRP3 inflammasome activation, defining the molecular events of 
NLRP3 inflammasome activation and expanding the role of LUBAC as an innate immune 
regulator. Furthermore, our observation is clinically relevant because patients lacking HOIL-
1L expression suffer from pyogenic bacterial immunodeficiency, providing a potential new 
therapeutic target for enhancing inflammation in immunodeficient patients.
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after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 























1334 Linear ubiquitination regulates NLRP3/ASC assembly | Rodgers et al.
AIM2–ASC inflammasome complex for destruction in au-
tophagosomes (Shi et al., 2012; Shimada et al., 2012). How-
ever, given the complexity of the regulation of the NF-B 
pathway by a combination of K63, K48, and linear ubiqui-
tination, further analysis of ubiquitination-mediated regula-
tion is necessary to fully understand inflammasome-induced 
innate immune pathways.
Besides its role in TLR-induced NF-B activation, 
LUBAC-mediated linear ubiquitination may also participate 
in the inflammasome activation pathway for caspase-1 activation 
and IL-1 secretion. However, the roles of LUBAC have so 
far been defined through the study of mouse embryonic fi-
broblasts (MEFs), B cells and keratinocytes of HOIL-1L/ and 
Sharpincpdm (null point mutant) mice, or human embryonic 
kidney (HEK293T) reporter cells with gene overexpression 
of knockdown conditions (Tokunaga et al., 2009, 2011; Gerlach 
et al., 2011; Ikeda et al., 2011) that do not express all of the 
subunits of the inflammasome family of PRRs, thus making 
the role of LUBAC in inflammasome pathways elusive. In this 
study, we thus examined the role of the HOIL-1L subunit of 
LUBAC in NLRP3 inflammasome pathway in primary 
BM-derived macrophages (BMDMs). We demonstrate that 
HOIL-1L is essential for NLRP3 inflammasome activation 
independently of NF-B activation. Specifically, HOIL-1L is 
required for ASC linear ubiquitination and NLRP3 inflam-
masome assembly, thus expanding the role of LUBAC as an 
innate immune regulator.
RESULTS
Cell type–specific roles of HOIL-1L in NF-B activation
To test whether NF-B is regulated by LUBAC in macro-
phage cells, we first examined NF-B activation in WT and 
HOIL-1L/ BMDMs and MEFs upon stimulation with 
LPS or TNF (Fig. 1). Similarly to previous studies (Tokunaga 
et al., 2009, 2011; Gerlach et al., 2011; Ikeda et al., 2011), 
HOIL-1L/ MEFs showed delayed kinetics of IB degra-
dation compared with WT MEFs upon LPS or TNF treat-
ment. In distinct contrast, HOIL-1L/ BMDMs had similar 
kinetics of IB degradation to WT BMDMs (Fig. 1 a), sug-
gesting that HOIL-1L may function in a cell type–dependent 
manner as previously shown in human patient samples (Boisson 
et al., 2012). As a result of reduced NF-B activation, HOIL-
1L/ MEFs had reduced expression of the IL-6, IB, and 
ICAM1 genes as compared with WT MEFs after 2 h of LPS 
treatment (Fig. 1 b). The relative abundances of IL-6 tran-
scripts in BMDMs and MEFs resulted in similar levels of IL-6 
cytokine secretion in WT and HOIL-1L/ BMDMs but 
significantly reduced IL-6 cytokine secretion in HOIL-1L/ 
MEFs compared with WT MEFs after 24 h of LPS stimula-
tion (Fig. 1 c), suggesting that HOIL-1L has cell type–specific 
functions for NF-B activation.
To further define the role of HOIL-1L in NF-B–dependent 
and –independent gene expression, we examined global 
mRNA transcripts by microarray and found that HOIL-
1L/ BMDMs had generally similar transcriptional profiles 
to WT BMDMs with or without LPS or TNF treatment (4 h; 
or both (Haas et al., 2009). LUBAC is required for the linear 
ubiquitination of Rip1 and Nemo, resulting in the activation 
of the IKK kinase (Iwai and Tokunaga, 2009). Phosphoryla-
tion of IB by IKK is required for the K48 ubiquitination 
of IB, which leads to proteasomal degradation of IB and 
release of the p50/p65 NF-B transcription factor for trans-
location to the nucleus (Iwai and Tokunaga, 2009). Although 
many protein substrates have been described for K48 and K63 
ubiquitination, few have been described for linear ubiquitina-
tion, with only Rip1 and Nemo being the best characterized. 
Negative regulators of linear ubiquitination-dependent NF-B 
activation have recently been reported, including the FAM105B 
(otulin) and CYLD linear ubiquitin-specific deubiquitinases 
(DUBs) and A20, which specifically binds the linear ubiquitin 
moiety and edits Rip1 ubiquitination to inhibit its activation 
(Wertz et al., 2004; Tokunaga et al., 2012; Verhelst et al., 2012; 
Keusekotten et al., 2013; Rivkin et al., 2013).
Because many receptor signaling pathways converge on 
Nemo activation, linear ubiquitination is expected to be re-
quired for the NF-B–dependent gene expression of various 
pattern recognition receptor (PRR) pathways. Indeed, TLRs, 
such as TLR2, 3, 4, 7/8, and 9, have been shown to require 
LUBAC for NF-B–dependent gene expression due to the 
linear ubiquitination of Nemo (Zak et al., 2011). The NOD2 
(nucleotide-binding oligomerization domain-containing 
protein 2)-dependent activation of NF-B in response to 
muramyl dipeptide (MDP) also requires LUBAC, which is re-
cruited by the XIAP-mediated K63 ubiquitination of RIPK2 
(Damgaard et al., 2012). In contrast, the HOIL-1L subunit of 
LUBAC is a negative regulator of the RIG-I intracellular 
virus-sensing PRR that competitively binds RIG-I and tar-
gets TRIM25 for degradation, thus stopping the TRIM25- 
mediated ubiquitination and activation of RIG-I as a potential 
feedback inhibitory pathway (Inn et al., 2011). These findings in-
dicate that LUBAC plays important roles in various surface and 
intracellular PPR pathways as a positive and negative factor.
The inflammasome family of PRRs detects cytosolic 
pathogens and danger signals, such as potassium efflux and 
mitochondrial damage, in myeloid-lineage cells and responds 
by forming an oligomer signaling complex that includes an 
adapter protein, such as ASC or Naip5, which can bind to 
pro–caspase-1 (Franchi et al., 2012). The inflammasome com-
plex subsequently potentiates the autocatalytic cleavage 
of pro–caspase-1 to its active p10 and p20 subunits, which 
enzymatically cleaves pro–IL-1 and pro–IL-18 to active 
cytokines for immediate secretion and inflammatory action 
(Schroder and Tschopp, 2010). Expression of the pro–IL-1 
gene is NF-B–dependent, and is triggered by a second PRR 
stimulation, such as TLRs, in macrophage cells (Schroder and 
Tschopp, 2010; Franchi et al., 2012). Regulation of inflam-
masomes by ubiquitination has previously been shown for the 
NLRP3 and AIM2 inflammasomes, which both use the ASC 
adapter protein (Franchi et al., 2012). The deubiquitination of 
NLRP3 by the BRCC3 complex is required for NLRP3 ac-
tivation ( Juliana et al., 2012; Lopez-Castejon et al., 2013; Py et al., 
2013), and the K63-linked ubiquitination of ASC targets the 
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expression (Zak et al., 2011), including a strong reduction of 
IL-1 transcript levels in Sharpincpdm BMDMs (Zak et al., 
2011). Therefore, we did not include these cells for further 
study of inflammasome activation.
HOIL-1L is required for ASC-dependent  
inflammasome activation
To determine whether HOIL-1L is a regulator of inflammasome- 
mediated caspase-1 activation, WT and HOIL-1L/ BMDMs 
were primed with LPS to induce the TLR4-dependent 
expression of pro–IL-1 protein, and subsequent activation 
of the NLRP3 inflammasome was achieved by treatment 
with nigericin, a potassium ionophore, silica particles, mono-
sodium urate crystals (MSUs), or the peptidoglycan compo-
nent MDP, followed by ATP treatment (Dostert et al., 2008; 
Hornung et al., 2008; Schroder and Tschopp, 2010; Kovarova 
et al., 2012). The AIM2 inflammasome was stimulated by 
double-stranded plasmid DNA (dsDNA) and the NLCR4 
inflammasome was stimulated by cytosolic delivery of puri-
fied Salmonella typhimurium–derived flagellin or infection 
Fig. 2 a), whereas a small number of transcripts were differen-
tially regulated in HOIL-1L/ BMDMs compared with WT 
BMDMs (Tables S1 and S2). These transcripts might be di-
rectly regulated by HOIL-1L because HOIL-1L was origi-
nally identified as a DNA-binding protein, although the 
transcripts regulated by HOIL-1L were not previously identi-
fied (Tatematsu et al., 1998; Tokunaga et al., 1998). Specific 
comparison of the selected NF-B–regulated transcripts fur-
ther revealed equivalent or higher levels of their expression in 
HOIL-1L/ BMDMs than in WT BMDMs, and pathway 
analysis confirmed that the NF-B pathway was regulated in 
a similar manner in WT and HOIL-1L/ BMDMs (Fig. 2 b). 
These expression profiles were additionally confirmed by 
quantitative PCR (qPCR) in WT and HOIL-1L/ BMDM 
(Fig. 2 c). Notably, IL-1 transcript levels were similar in 
HOIL-1L/ and WT BMDMs upon LPS treatment, con-
firming that LPS treatment is a suitable priming signal for 
inflammasome activation experiments in these cells. Previous 
microarray data of TLR2-activated WT and Sharpincpdm 
BMDMs showed an obvious defect in NF-B–dependent gene 
Figure 1. HOIL-1L has cell type–specific roles in NF-B activation. (a) WT and HOIL-1L/ MEFs and BMDMs were stimulated with 1 ng/ml TNF or 
10 ng/ml LPS for 0, 15, or 30 min and probed for indicated protein levels by immunoblotting. Data are representative of three independent experiments. 
(b) The mRNA transcript abundance for selected NF-B–regulated genes was quantified after 2 h of 10 ng/ml LPS stimulation by qRT-PCR (biological n = 2). 
Data are representative of two independent experiments. (c) IL-6 secretion was quantified by ELISA at 24 h after LPS treatment (biological n = 3). Data  
are representative of three independent experiments. Protein size markers are indicated in kD. All data are presented as the mean ± SEM by a Student’s  
t test. *, P = 0.013; **, P = 0.015; ***, P = 0.034; #, P = 106.
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Franchi et al., 2012) inflammasomes both require the adapter 
protein ASC, whereas the NLRC4 inflammasome is only en-
hanced by ASC (Broz et al., 2010; Miao et al., 2010; Zhao 
et al., 2011). Thus, these results indicate that HOIL-1L may 
specifically be required for ASC-dependent inflammasome ac-
tivation. Although the IL-1 secretion induced by both NLRP3 
and AIM2 inflammasomes were affected in HOIL-1L/ 
with Legionella pneumophila without any additional priming. 
Compared with WT BMDMs, HOIL-1L/ BMDMs had a 
defect in mature IL-1 secretion upon NLRP3 stimulation, 
reduced IL-1 secretion upon AIM2 stimulation, but similar 
IL-1 secretion upon NLRC4 stimulation (Fig. 3 a). Interest-
ingly, the AIM2 (Fernandes-Alnemri et al., 2009; Rathinam 
et al., 2010) and NLRP3 (Martinon et al., 2002; Pan et al., 2007; 
Figure 2. Global transcriptional profiles of WT and HOIL-1L/ BMDMs in response to LPS and TNF. (a) Heat map of genes with fivefold or 
greater changes in expression by whole genome microarray comparison were grouped by hierarchal clustering for WT and HOIL-1L/ BMDMs treated with 
1 ng/ml TNF for 4 h, 10 ng/ml LPS for 4 h, or untreated for 4 h (biological n = 2, data for both individual replicates are presented as samples 1 and 2 for 
each condition). (b) Heat map of selected NF-B genes compared by hierarchal clustering (biological n = 2, data for both individual replicates are presented 
as samples 1 and 2 for each condition). (c) Analysis of mRNA transcript abundance by qRT-PCR for selected genes as indicated in WT and HOIL-1L/ BMDMs 
stimulated as in a (biological n = 2 and analytical n = 2 for each biological replicate). All data are presented as the mean ± SEM by a Student’s t test.
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Figure 3. LUBAC is required for NLRP3 inflammasome activation in BMDMs. (a) IL-1 secretion as determined by ELISA of WT or HOIL-1L/ BMDMs 
primed with LPS overnight and stimulated with nigericin, silica, MSU, MDP followed by ATP, dsDNA transfected by lipofectamine, or infected with adenovirus-
Flagellin as indicated. Unprimed BMDMs were infected with L. pneumophila at indicated multiplicities of infection (MOIs). Data are presented as the mean ± 
SEM by a Student’s t test (biological n = 3 and are representative of two independent experiments; *, P < 0.00033; #, P = 0.011). (b) Protein expression  
and caspase-1 cleavage of WT or HOIL-1L/ BMDMs untreated or primed with LPS and stimulated with nigericin was analyzed by immunoblotting.  
(c) BMDMs primed with LPS and stimulated with nigericin were treated with FAM-YVAD-FLICA fluorescent caspase-1 substrate during MDP treatment, 
fixed, and then stained for caspase-1. The percentage of FLICA-positive cells was determined for 250 total cells. Arrows point to FLICA-stained spots. Bars, 
20 µm. (d–h) WT or HOIL-1L/ BMDMs were complemented with lentiviral vectors expressing mutants described in d and analyzed for: (e) IL-1 secretion 
by ELISA (biological n = 3 and analytical n = 2; data presented as the mean ± SEM; **, P < 0.0075; #, P < 0.013 by a Student’s t test); (f) mRNA quantifica-
tion by qRT-PCR; (g) protein expression by immunoblot; and (h) quantification of FLICA staining for active caspase-1. All data are representative of three 
independent experiments except for c and h, which depict combined data for all three experiments. Protein size markers are indicated in kD.
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regulator for the NLRP3 stimulation-dependent activation of 
caspase-1 activity.
To define the role of linear ubiquitination in inflam-
masome activation, we complemented the HOIL-1L/ 
BMDMs with HA-tagged WT or mutant HOIL-1L (Fig. 3 d). 
These mutants are as follows: the UBL mutant carrying de-
letion of the ubiquitin-like (UBL) domain that is required 
for binding to HOIP to achieve linear ubiquitination activ-
ity (Kirisako et al., 2006; Stieglitz et al., 2012); the NZF 
and TF mutants carrying deletion and T203L/F204V point 
mutations, respectively, of the Npl4 type-zinc-finger (NZF) 
domain that is required for binding to ubiquitin (Haas et al., 
2009; Sato et al., 2011); and the RBR mutant carrying dele-
tion of the Ring-between-Ring (RBR) domain that is an E3 
ubiquitin ligase domain. As expected, pro–IL-1 mRNA and 
BMDMs, the effect was much more pronounced for NLRP3 
stimulation than for AIM2 stimulation, leading us to further 
characterize the mechanism of HOIL-1L–mediated regula-
tion of NLRP3–ASC inflammasome activation. Although 
WT BMDMs had NLRP3 stimulation-dependent caspase-1 
activity, as measured by pro–caspase-1 cleavage to the p10 
subunit, HOIL-1L/ BMDMs showed a defect in pro– 
caspase-1 cleavage under the same stimulation conditions 
(Fig. 3 b). Similarly, when BMDMs were stained with FAM-
YVAD-FMK (FLICA), a fluorescent caspase-1 substrate pep-
tide which selectively binds cleaved and active caspase-1 
enzyme, only WT BMDMs contained FLICA-staining posi-
tive active caspase-1 upon NLRP3 stimulation, whereas 
HOIL-1L/ BMDMs had reduced FLICA staining (Fig. 3 c). 
Together, these data demonstrate that LUBAC is a critical 
Figure 4. Assembly of the NLRP3/ASC inflammasome requires HOIL-1L. (a) Representative images of ASC foci formation (arrows) upon NLRP3 
stimulation in WT or HOIL-1L/ BMDMs with ASC staining in green, linear ubiquitin in red, and nuclei in blue. Bar, 20 µm. Images are from one of four 
independent experiments. (b) Quantification of ASC foci in 100 cells counted from images in a. (c) Z-stack of WT BMDMs in a. Bar, 10 µm. (d) Representa-
tive images of ASC foci formation (arrows) upon NLPR3 stimulation in HOIL-1L/ and WT BMDMs infected with indicated lentiviruses and stained as 
described for a. Bar, 20 µm. Images are from one of two independent experiments. (e) Quantification of ASC foci from 30 cells combined from three ex-
periments from images in d. (f) IP of ASC from untreated WT and HOIL-1L/ BMDMs or after LPS priming and nigericin stimulation, data are representa-
tive of four independent experiments. Protein size markers are indicated in kD.
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LUBAC expression (Fig. 5 a) and that ASC was detected as 
multi-laddered and high molecular weight bands in the linear 
ubiquitin immunoprecipitations (IPs), suggesting that ASC is 
a LUBAC substrate (Fig. 5 a). In addition, NEMO was also 
detected in the linear ubiquitin IP (Fig. S1) consistent with 
previous results (Tokunaga et al., 2009), whereas AIM2 and 
NLRP3 showed no linear ubiquitination (Fig. 5 a), demon-
strating the substrate selectivity of LUBAC-mediated linear 
ubiquitination in 293T cells. Comparison of the E3-ligase 
activity in cells co-expressing different combinations of the 
WT or E3 ligase-defective “cs” mutants of HOIP and HOIL-
1L—which have cysteine to serine point mutations at con-
served residues of the RING domains in the C-terminal 
RBR region (Kirisako et al., 2006; Inn et al., 2011; Stieglitz 
et al., 2012)—revealed that the E3 ligase activities of both 
HOIP and HOIL-1L were required for the efficient linear 
ubiquitination of ASC. Specifically, expression of the HOIL-
1L cs mutant markedly reduced levels of ASC linear ubiqui-
tination, and expression of the HOIP cs mutant led to 
undetectable levels of ASC linear ubiquitination (Fig. 5 b). 
Linear ubiquitination does not appear to lead to the degrada-
tion of ASC by the proteasome because inhibition of the pro-
teasome with MG132 did not affect levels of total or linear 
ubiquitinated ASC (Fig. 5 c). Consistently, endogenous ASC 
protein levels were comparable in WT and HOIL-1L/ cell 
lysates (Fig. 4 f; and Fig. 6, a and b). These data are consistent 
with the presumed nondegradative effect of linear ubiquitina-
tion on the Nemo and Rip1 substrates (Iwai and Tokunaga, 
2009; Tokunaga et al., 2009), and indicate that both the HOIP 
and HOIL-1L E3 ligase activities are required for the efficient 
linear ubiquitination of ASC.
In a second method for testing whether ASC is a LUBAC 
substrate, we purified linear ubiquitinated proteins from trans-
fected 293T lysates with a bacterially produced GST fusion to 
the coiled zipper (CoZi) domain of NEMO that has been 
shown to specifically bind to both K63 and linear ubiquitin 
chains (Komander et al., 2009; Rahighi et al., 2009). In parallel, 
a GST-CoZi mutant fusion containing the R309A, R312A, 
E313A (rre) mutant, which cannot bind to linear ubiquitin 
chains but is capable of binding to K63-linked ubiquitin chains 
in vitro (Komander et al., 2009), was included as a control. Con-
sistent with the linear ubiquitin IPs, the GST-CoZi purification 
pulled down ASC-Flag with multi-laddered high molecular 
weights in a LUBAC expression dependent manner, whereas 
the GST-CoZi rre mutant did not (Fig. 5 d), further supporting 
the LUBAC-mediated linear ubiquitination of ASC. More-
over, ASC linear ubiquitination was exclusively detected when 
HOIL-1L and HOIP were coexpressed, indicating that the lin-
ear ubiquitination of ASC is LUBAC-dependent (Fig. 5 d). In a 
third method, an in vitro ubiquitination assay also showed that 
HOIP-HOIL-1L co-purified from a bacterial expression sys-
tem specifically ubiquitinated ASC-Flag protein to levels that 
were comparable to the previously identified Nemo substrate 
(Tokunaga et al., 2009; Fig. 5 e), indicating that the LUBAC, E1, 
and E2 enzymes are sufficient for the linear ubiquitination 
of ASC. When NLRP3-Flag was included as a control, no 
protein levels were not affected by WT or mutant HOIL-1L 
gene expression (Fig. 3, f and g). Complementation of HOIL-
1L/ BMDMs with WT HOIL-1L fully rescued pro– 
caspase-1 cleavage, caspase-1 activity, and IL-1 secretion 
(Fig. 3, e–h). However, deletion of the UBL, NZF, or RBR 
domain of HOIL-1L failed to restore pro–caspase-1 cleavage, 
caspase-1 activity, or IL-1 secretion (Fig. 3, e–h). Together, 
these data indicate that nearly all the functional components 
of HOIL-1L, including the N-terminal HOIP interaction, 
the central ubiquitin interaction, and the C-terminal ubiqui-
tination ligase activity, are critical for pro–caspase-1 cleavage 
and enzymatic activity in NLRP3-inflammasome activation.
HOIL-1L is required for NLRP3/ASC inflammasome assembly
We next examined whether linear ubiquitination was impor-
tant for inflammasome activation events occurring upstream 
of caspase-1 cleavage, namely, ASC cytoplasmic foci forma-
tion and NLRP3–ASC complex assembly. Similarly to previ-
ous reports (Bryan et al., 2009; Shi et al., 2012; Proell et al., 
2013), ASC had diffuse localization in unstimulated WT 
BMDMs and could be found in distinct cytoplasmic foci 
upon NLRP3 stimulation (Fig. 4, a and b). Furthermore, 
when WT BMDMs were stained with a linear ubiquitin- 
specific antibody, ASC foci effectively colocalized with linear 
ubiquitination-containing compartments; Z-stack confocal 
imaging revealed that the linear ubiquitination-containing 
compartments appeared to be in the center of the ASC foci 
(Fig. 4 c and Video 1). Complementation of HOIL-1L/ 
BMDMs with HOIL-1L fully rescued ASC foci formation 
and the colocalization of ASC foci with linear ubiquitin stains 
to nearly the same levels as WT BMDMs (Fig. 4, d and e). Al-
though linear ubiquitination-containing compartments were 
detectable in HOIL-1L/ BMDMs, they did not colocalize 
with the ASC that remained diffuse throughout the cyto-
plasm in either untreated or NLRP3-stimulation conditions 
(Fig. 4 a). Furthermore, immune purification showed the 
efficient formation of the NLRP3–ASC complex in LPS-
primed, nigericin-stimulated WT BMDMs (Fig. 4 f). By 
marked contrast, the formation of the NLRP3–ASC complex 
was reduced to background levels in HOIL-1L/ BMDMs 
under the same conditions (Fig. 4 f). These results indicate a 
critical role of LUBAC in ASC foci formation and NLRP3–
ASC inflammasome assembly.
ASC is linear ubiquitinated by LUBAC
Because ASC foci colocalized with linear ubiquitin-containing 
compartments in WT BMDMs upon NLRP3 stimulation, 
we evaluated by five different assays whether ASC is a potential 
LUBAC substrate. First, we used a linear ubiquitin-specific 
antibody to immunoprecipitate linear ubiquitin from 293 
T cells transfected with the LUBAC subunits HOIL-1L and 
HOIP, along with a C-terminal Flag-tagged ASC (ASC-Flag) 
in 5M urea denaturation buffer conditions as optimized 
(Fig. S1) and as previously described (Matsumoto et al., 2012). 
Linear ubiquitin-specific immunoblotting indicated that high 
levels of linear ubiquitinated proteins were produced upon 
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NLRP3 stimulation but were reduced in HOIL-1L/ BMDMs, 
whereas total ubiquitin levels remained the same (Fig. 6, a–d). 
Linear ubiquitin IP from WT BMDMs in 5M urea buffer pre-
cipitated the high molecular weight ASC protein, which was 
enhanced by NLRP3 stimulation (Fig. 6 a), indicating that en-
dogenous ASC is linear ubiquitinated. Furthermore, levels of 
total linear ubiquitin and the linear ubiquitinated ASC were 
considerably reduced in HOIL-1L/ BMDMs under NLRP3 
stimulation conditions when compared with those in WT 
BMDMs (Fig. 6 b). Collectively, these results demonstrate that 
ASC is a specific substrate of LUBAC in overexpression and 
endogenous conditions.
detectable in vitro linear ubiquitination of NLRP3 was ob-
served under the same conditions (Fig. 5 e). In a fourth assay, lin-
ear ubiquitin immunoprecipitates were treated with the linear 
linkage-specific deubiquitinase Otulin, or the K63 linkage-
specific deubiquitinase AMSH, to determine whether the ubiq-
uitin chains on ASC were simply linear linkage or a mixture of 
K63 and linear linkages, which has previously been reported for 
other LUBAC substrates (Emmerich et al., 2013). Only the 
Otulin treatment reduced high molecular weight ASC, whereas 
the AMSH treatment had no effect (Fig. 5 f). Lastly, in a fifth 
assay, the linear ubiquitin IP of BMDM lysates indicated that 
overall linear ubiquitin levels increased in WT BMDMs upon 
Figure 5. ASC is linear ubiquitinated by 
LUBAC in 293T cells and in vitro. (a) Flag-
tagged ASC, AIM2, or NLRP3 were cotransfected 
with HOIL-1L-HA and myc-HOIP into 293T cells. 
Linear ubiquitinated proteins were immunopre-
cipitated. WCL (whole cell lysate) or immuno-
precipitates (IP Lin Ub) were immunoblotted for 
Flag and linear ubiquitin. (b) 293T cells were 
transfected with a panel of WT HOIL-1L-HA and 
Flag-HOIP or RBR E3 ligase domain cysteine to 
serine point mutants (cs) and probed by linear 
ubiquitin IP for ASC-V5, HA, and Flag as indi-
cated. (c) Transfected 293T cells were treated 
for 6 h with 20 µM MG132 or an equivalent 
volume of DMSO before lysates were collected 
and immunoprecipitated with linear ubiquitin 
antibody. Immunoprecipitates were probed for 
linear ubiquitin, Flag, and ubiquitin as indicated. 
(d) Bacterially purified GST-CoZi wt and rre 
proteins were incubated with lysates from  
293T cells transfected with ASC-Flag, HOIL-
1L-HA, and myc-HOIP or vector control plas-
mids (left, input). Proteins that were pulled 
down by WT or rre mutant GST-CoZi were 
probed for linear ubiquitin or Flag by immuno-
blotting (right, GST-Cozi PD). (e) ASC-Flag and 
NLRP3-Flag were purified from 293T lysates in 
a nondenaturing high salt buffer (500 mM 
NaCl) and combined as indicated with E1 
(Ube1), E2 (UbcH5c), and LUBAC (HOIL-1L/HOIP) 
purified from bacteria in a linear ubiquitination 
reaction that was incubated for 18 h at 37°C. 
Reactions were stopped by the addition of load-
ing dye and immunoblotted for Flag. Mem-
branes were then stripped and reprobed for 
linear ubiquitin. (f) Deubiquitinase treatment of 
linear ubiquitin immunoprecipitates from 293T 
cell lysates overexpressing HOIL-1L-HA, myc-
HOIP, and ASC-V5. Reactions were immuno-
blotted for linear ubiquitin and V5. Control 
purified ubiquitin chains were incubated in 
parallel in deubiquitinase reactions that were 
immunoblotted with a linkage nonspecific anti-
body against ubiquitin (Ub). All data are repre-
sentative of a minimum of three independent 
experiments. * indicates unmodified size. Pro-
tein size markers are indicated in kD.
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IP cavity after injection with MDP (Fig. 7). Interestingly, IL-
1 production and neutrophil recruitment were significantly 
reduced in HOIL-1L/ mice compared with WT mice, 
whereas IL-6 production was similar in WT and HOIL-1L/ 
mice (Fig. 7). These results suggest that HOIL-1L is required 
for NLRP3-dependent IL-1 production and neutrophil re-
cruitment, but not for NOD2-dependent IL-6 production, in 
MDP-induced peritonitis in vivo.
We also examined the role of HOIL-1L in an LPS-induced 
systemic inflammation mouse model in vivo, which is depen-
dent on several inflammatory signaling molecules including 
TLR4, NLRP3, ASC, and IL-1 (McNamara et al., 1993; 
Mariathasan et al., 2004, 2006; Joosten et al., 2010; Kayagaki 
et al., 2013). The WT control mice rapidly succumbed to LPS 
challenge beginning at 24 h after injection and continuing 
until 72 h after injection. The WT mice also showed high lev-
els of inflammation as measured by hematoxylin, eosin, and 
apoptotic marker Annexin V staining of spleen sections at 
24 h after injection (Fig. 8, a and b), indicating that excessive 
inflammation contributed to the deaths of the WT mice. In 
contrast, 100% of the HOIL-1L/ mice survived LPS challenge 
despite significant weight loss (Fig. 8, a and c). HOIL-1L/ 
mice also had significantly lower serum IL-1 levels and 
Annexin-V staining of splenic sections at 24 h after injection 
(Fig. 8, b and d), suggesting the HOIL-1L/ mice had re-
duced inflammatory responses. Because NLRP3/ and 
ASC/ mice are also resistant to LPS in this mouse model 
(Mariathasan et al., 2004, 2006), the role of HOIL-1L in NLRP3 
inflammasome activation characterized here may also contrib-
ute to the survival of HOIL-1L/ mice in the LPS-induced 
lethal inflammation model in vivo.
DISCUSSION
Here, we demonstrate that HOIL-1L is specifically required 
for NLRP3 inflammasome-dependent IL-1 secretion in 
BMDMs independently of NF-B activation. Mechanisti-
cally, the assembly of the NLRP3/ASC inflammasome and 
linear ubiquitination of the novel LUBAC substrate, ASC, 
both require HOIL-1L expression. The loss of these functions 
in HOIL-1L/ mice results in resistance to MDP-induced 
peritonitis and contributes to survival upon LPS-induced sys-
temic inflammation. This is the first demonstration that linear 
ubiquitination is required for NLRP3/ASC-dependent in-
flammasome activation, thus expanding the role of LUBAC 
as an innate immune regulator. This work is also the first 
to compare the role of HOIL-1L in MEF and macrophage 
cells. Our data indicate that HOIL-1L is critical for NF-B 
activation in MEF cells, consistent with the literature (Fig. 1; 
Tokunaga et al., 2009; Gerlach et al., 2011; Ikeda et al., 2011). 
However, this activity is cell type specific because HOIL-1L 
is not required for NF-B activation or NF-B–dependent 
gene expression in BMDMs (Figs. 1 and 2). These observa-
tions are likely clinically relevant because patients lacking 
functional HOIL-1L expression had an IL-6 response to LPS 
that was equivalent to control patient levels when whole 
blood cells were stimulated (Boisson et al., 2012), which is 
Role of HOIL-1L in NLRP3-induced IL-1 production  
and inflammation in vivo
Previous reports of the MDP-induced peritonitis mouse 
model (Bruey et al., 2007; Pan et al., 2007; Shenoy et al., 
2012) have demonstrated that NOD2, a cytosolic PRR in the 
NLR family, is required for NF-B–mediated IL-6 produc-
tion, whereas NLRP3 is required for IL-1 secretion and 
neutrophil recruitment in i.p. cavity. Thus, we tested whether 
HOIL-1L was important for proinflammatory cytokine pro-
duction and neutrophil recruitment in the MDP-induced 
peritonitis mouse model. As expected, WT mice had increased 
IL-6 and IL-1 production and neutrophil recruitment to the 
Figure 6. Endogenous mouse ASC is linear ubiquitinated in BM-
DMs. (a) WT BMDMs were untreated or primed with LPS overnight and 
stimulated with nigericin for 2 h before IP with a linear ubiquitin-specific 
antibody in 5M urea denaturing conditions. Immunoprecipitates (IP Lin Ub) 
and whole cell lysates (WCL) were immunoblotted for ASC and linear ubiq-
uitin (Lin Ub). (b) WT and HOIL-1L/ BMDMs were primed with LPS over-
night and stimulated with nigericin for 2 h before IP with an ASC-specific 
antibody and extensive washing in high salt buffer (500 mM NaCl). Immuno-
precipitates and WCLs were immunoblotted for ASC and linear ubiquitin. 
(c) WT BMDMs were primed with LPS overnight and stimulated with nige-
ricin for 2 h before IP with a linear ubiquitin-specific antibody or an equiv-
alent amount of control human antibody in 5M urea denaturing 
conditions. Immunoprecipitates and WCL were immunoblotted for linear 
ubiquitin. (d) WCL extracts from lysates in c were immunoblotted for ubiq-
uitin with a linkage nonspecific antibody (Ub). All data are representative 
of two independent experiments. Protein size markers are indicated in kD.
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cells. In fact, the dermatitis phenotype observed in Sharpincpdm 
mice is reversed by NF-B inhibitor treatment (Liang et al., 
2011) or knockout of the TNF gene (Gerlach et al., 2011), 
further supporting cell type–dependent roles for Sharpin.
Our microarray data results indicated that expression of 
several genes was up-regulated in HOIL-1L/ BMDM rela-
tive to WT BMDM in response to LPS and TNF stimulation 
(Fig. 2 a and Table S2), suggesting that HOIL-1L is perhaps a 
negative regulator of LPS- and TNF-mediated signaling in 
BMDMs. It is possible that our list of genes for which tran-
scription levels are significantly different in HOIL-1L/ 
BMDMs compared with WT BMDMs includes those that 
HOIL-1L may directly regulate as a potential transcription 
factor (Tatematsu et al., 1998; Tokunaga et al., 1998; Tables S1 
and S2). However, the majority of genes in the list are unchar-
acterized, making the relevance of HOIL-1L–mediated regu-
lation of their gene expression unclear. A previous microarray 
compared WT and Sharpincpdm BMDMs upon stimulation of 
similar to our results in BMDMs (Fig. 2, b and c). However, 
IL-6 production was attenuated in fibroblast cells of HOIL-
1L–deficient patients (Boisson et al., 2012) similarly to our 
results with HOIL-1L/ MEFs (Fig. 1 c), indicating that the 
tissue-specific functions for HOIL-1L also exist in humans. 
Because HOIL-1L–deficient patients were prone to pyogenic 
bacterial infections (Boisson et al., 2012), we predict that a 
defect likely exists in NLRP3 inflammasome assembly in 
these patients, similar to what we have observed in BMDMs 
from HOIL-1L/ mice, leading to ineffective innate immu-
nity upon exposure to bacterial pathogens. In addition to cell 
type–specific functions for HOIL-1L, the LUBAC subunit 
Sharpin may also have tissue-specific roles. It has been reported 
that Sharpincpdm MEFs (Gerlach et al., 2011; Ikeda et al., 2011; 
Tokunaga et al., 2011) and BMDMs (Zak et al., 2011) have 
defects in NF-B signaling, yet skin cells from Sharpincpdm 
mice have elevated NF-B activation (Liang, 2011; Liang et al., 
2011), suggesting that Sharpin has unique functions in skin 
Figure 7. HOIL-1L is required for MDP-induced peri-
tonitis in vivo. WT and HOIL-1L/ mice were injected i.p. 
with PBS or MDP to induce peritonitis. 5 h later, IP wash 
fluid was analyzed for IL-1 (a) and IL-6 (b) levels by ELISA 
and infiltrating Ly6G/CD11b double-positive neutrophils  
(c and d) were quantified by flow cytometry (biological n = 8 
from three independent experiments). All data are presented 
as the mean ± SEM. *, P < 0.00015 by a Student’s t test.
Figure 8. HOIL-1L is required for lethal inflamma-
tion upon LPS challenge in vivo. (a) Survival curve for 
WT or HOIL-1L/ mice challenged with 30 mg/kg LPS  
(n = 10, combined from three independent experiments).  
(b) Apoptotic marker Annexin-V (red) and hematoxylin-
eosin (H&E)–stained spleen sections from mice in a, sac-
rificed 24 h after LPS injection. Images are representative 
of three analyzed mice for each condition. Bar, 100 µm.  
(c) Weight curve of mice from a. (d) Serum IL-1 levels 
from WT and HOIL-1L/ mice sacrificed 24 h after LPS 
injection were determined by ELISA (n = 4, combined 
from 2 independent experiments). Data are presented as 
the mean ± SEM. *, P < 0.0001 by a Log-rank Mantel-Cox 
test; **, P = 0.0015; ***, P < 0.008 by a Student’s t test.
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ASC. However, our attempts to map the ubiquitinated resi-
dues of ASC indicate that mutagenesis of the lysines in ASC 
affects protein–protein interactions independently of linear 
ubiquitination, making finer evaluation of the role of ASC 
linear ubiquitination for inflammasome activation difficult. 
Furthermore, as shown in the Nemo linear ubiquitination 
studies (Tokunaga et al., 2009, 2011; Gerlach et al., 2011; 
Ikeda et al., 2011), the levels of endogenous linear ubiquitina-
tion of Nemo seem to be very low. Thus, additional technical 
advances are necessary to define the specific roles of linear 
ubiquitination in intracellular signaling pathways.
Our data supports the hypothesis that each type of inflam-
masome has unique regulatory mechanisms, although the de-
tailed mechanisms for these events have not been completely 
described. In particular, the NLRP3 inflammasome is distinct 
from other inflammasome sensors because it responds to a 
wide variety of triggers instead of one or two specific ligands 
like AIM2 or NLRC4 (Schroder and Tschopp, 2010; Franchi 
et al., 2012). Although mitochondrial damage is a common 
source for the potential NLRP3 stimulating signals, including 
mitochondrial ROS, oxidized mitochondrial DNA, and mi-
tochondrial cardiolipin (Nakahira et al., 2011; Shimada et al., 
2012; Iyer et al., 2013), the molecular events preceding the 
NLRP3/ASC interaction are not well characterized. Thus, it 
remains unknown what triggers HOIL-1L–containing LUBAC 
to linear ubiquitinated ASC upon NLRP3 stimulation. A re-
cent report identified the phosphorylation of ASC as a trigger 
for the NLRP3 and AIM2 inflammasomes, although it is not 
clear whether this phosphorylation event affects the ubiqui-
tination of ASC (Hara et al., 2013). Because the molecular 
events triggering caspase-1 cleavage are also unclear, the mech-
anisms of NLRP3 activation must be further defined to char-
acterize which events happen first. Nevertheless, our work has 
added linear ubiquitination to the sequence of events that 
precede NLRP3/ASC inflammasome assembly.
The resistance of HOIL-1L/ mice to lethal inflamma-
tion (Fig. 8) emphasizes the role of HOIL-1L as a critical reg-
ulator of inflammation in vivo despite the absence of dermatitis 
phenotype that is observed in the Sharpincpdm mice (Gerlach 
et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). Given 
that the accurate mechanisms responsible for the symptoms of 
lethal inflammation in mouse models are not fully under-
stood (Kayagaki et al., 2013; Seok et al., 2013), it is likely that 
HOIL-1L/ mice are resistant to death because of complex 
multifaceted roles of HOIL-1L in inflammation, but not due 
to its action in a single pathway. Thus, the overall survival of 
the HOIL-1L/ mice is likely due to a combination of vari-
ous roles of HOIL-1L in different pathways, including NLRP3 
activation, NF-B–dependent TNF, IL-1, CD40, and NOD2 
receptor signaling (Haas et al., 2009; Iwai and Tokunaga, 2009; 
Tokunaga et al., 2009; Zak et al., 2011; Damgaard et al., 2012), 
protein kinase C activity (Nakamura et al., 2006), RIG-I acti-
vation (Inn et al., 2011), and transcriptional regulation as a 
DNA-binding protein (Tatematsu et al., 1998; Tokunaga et al., 
1998). Interestingly, the HOIL-1L/ mice never displayed any 
behavioral symptoms of LPS-induced lethal inflammation 
TLR2 with bacterial lipoprotein Pam3CSK4 and found a signif-
icant defect in NF-B–dependent transcription in Sharpincpdm 
BMDMs (Zak et al., 2011). Because HOIL-1L/ mice do not 
exhibit the severe dermatitis phenotypes of the Sharpincpdm 
mice (Gerlach et al., 2011; Ikeda et al., 2011), it is not sur-
prising to find that these LUBAC members have different 
roles in various signaling pathways. In contrast to our obser-
vation that IL-6 secretion is not impaired in HOIL-1L/ 
mice in response to MDP (Fig. 7), a previous study reported 
that Sharpincpdm BMDMs have a defect in MDP-dependent 
IL-6 secretion, although an in vivo peritonitis model was not 
used in this study (Damgaard et al., 2012). This difference could 
also be due to the use of lipid modified MDP (L18-MDP) in 
the previous study, or it could indicate that HOIL-1L and 
Sharpin may have different roles in NOD2 stimulation. Addi-
tional reports that LUBAC is recruited to the NOD2 receptor 
complex in response to MDP suggest that this recruitment re-
quires XIAP. However, the role of LUBAC was not directly tested 
in these studies. In addition, the defects in XIAP-deficient 
cells and Otulin-expressing cells could be due to LUBAC- 
independent functions of XIAP or difference of nonmacro-
phage cell types used in these studies (Damgaard et al., 2013; 
Keusekotten et al., 2013). Further study is necessary to resolve 
the detailed roles of LUBAC in gene expression regulation.
Ubiquitination is a posttranslational modification that 
creates versatility in intracellular signaling. Specifically, K63 
linkage is exclusively responsible for ubiquitin-mediated non-
degradative signaling functions and linear linkage is crucial in 
various receptor and PRR pathways. Our discovery of ASC 
as a LUBAC substrate is related to a previous report that ASC 
is ubiquitinated upon AIM2 stimulation (Shi et al., 2012), al-
though K63-linked ubiquitination was reported. Because K63 
antibodies can cross-detect linear ubiquitination (Matsumoto 
et al., 2012) and the K63 E3 ligase or ASC lysine targets were 
not identified, it may be possible that the ubiquitination in 
this previous study was actually linear ubiquitination. Ubiqui-
tination of NLRP3 has also been reported (Lopez-Castejon 
et al., 2013; Py et al., 2013); however, this ubiquitination is not 
likely to be linear because the N-terminal His-tagging of 
ubiquitin used in this study would eliminate the possibility of 
a linear methionine-to-glycine linkage (Gerlach et al., 2011). 
Previous characterization of Nemo as a LUBAC substrate 
used 293T overexpression systems, reporter assays, and in vitro 
assays (Tokunaga et al., 2009, 2011; Gerlach et al., 2011; Ikeda 
et al., 2011). Our results demonstrate that ASC is a LUBAC 
substrate using similar assays, with additional endogenous evi-
dence in BMDMs (Figs. 5 and 6). Previous mapping of the 
Nemo protein led to the identification of two lysine targets 
for LUBAC, which were functionally required for NF-B 
activation in MEF cells (Tokunaga et al., 2009). We also ex-
pect that two linear ubiquitination sites may exist on ASC 
based on the results from our deubiquitination assay (Fig. 5 f). 
Because Otulin can more efficiently cleave linear ubiquitin link-
ages than ubiquitin-substrate linkages, the two higher molec-
ular weight ASC bands that remained after Otulin treatment 
(Fig. 5 f) may correspond to two direct ubiquitination sites on 
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were a gift from S.-Y. Chen (University of Southern California) and L. pneu-
mophila stocks were a gift from F. Shao (National Institute of Biological Sci-
ences, Beijing, China). Lentiviruses were produced in 293T cultured in 
DMEM supplemented with 10% FCS, 100 U/ml penicillin, and 100 µg/ml 
streptomycin using the pCDH-CMV-MCS-EF1-puro system (System Bio-
sciences) and standard calcium phosphate transfection. BMDMs were in-
fected with lentivirus on day 3 or 4 after thawing in 24-well plates. BMDMs 
were infected by centrifugation for 30 min at 2,000 rpm in fresh media con-
taining 8 µg/ml polybrene and 60–100 µl of virus stock per well as deter-
mined by titration of lentiviruses for equal protein expression. The inoculum 
was exchanged for fresh media after overnight incubation. Stimulations of 
lentivirus-infected BMDM were performed 7 d after thawing cells.
Microarray hybridization and analysis. RNA was isolated from BMDMs 
cultured in 10-cm dishes and treated with media alone, 10 ng/ml LPS, or 
1 ng/ml TNF for 4 h on day 7 of differentiation. RNA was prepared by an 
RNeasy kit (QIAGEN). For each condition, 2 separate 10-cm dishes were 
used to generate 2 separate RNA preparations, n = 2. 8 × 60k array hybrid-
izations (Agilent Technologies) were performed by UCLA Clinical Micro-
array Core according to standard protocol. Data were analyzed using the 
Genomics Suite (6.4; Partek). We used the RMA algorithm for data normal-
ization. Thresholds for selecting significant genes were set at twofold or 
greater and FDR P < 0.05. Genes met both criteria simultaneously were 
considered as significant changes. NF-B pathway analyses were performed 
using Ingenuity Pathway Analysis (Ingenuity Systems). The complete mi-
croarray dataset is accessible at NCBI GEO (GSE57180).
qRT-PCR. RNA was isolated from BMDM or MEF cells with 1 ml Tri 
Reagent (Sigma-Aldrich) and treated with 1 U RNase free DNase I (Sigma-
Aldrich). cDNA was generated from 250 ng of total RNA (iScript; Bio-Rad 
Laboratories), diluted 1:10 with nuclease-free water, and quantified by real-
time qPCR using the iQ SYBR Green Supermix kit (Bio-Rad Laborato-
ries), according to the manufacturer’s instructions. Reactions were cycled and 
analyzed on a CFX96 PCR machine (Bio-Rad Laboratories). Cycling con-
ditions were a single step at 95°C for 5 min, followed by 40 cycles of 95°C 
for 15 s and 60°C for 30 s, followed by melt curve analysis. Primer sequences 
are summarized in Table S3. Threshold cycle (Ct) ratios were determined by 
normalizing to 18S RNA and a WT control sample using the following 
equation: relative expression = 100*2(Ct), where Ct = (Ctgene  Ct18S)  
(CtWT unstimulated).
Cytokine quantification. Cytokines in cell culture supernatants were 
quantified by mouse IL-6 (BD) and mouse IL-1 ELISA kits (eBioscience). 
IL-1 levels in mouse sera were quantified using a custom multiplexing Mil-
liplex MAP mouse cytokine assay (Millipore) and analyzed on a Bio-Plex 
plate reader using Bio-Plex Manager software (Bio-Rad Laboratories) at the 
USC Norris Immune Monitoring Core.
Flow cytometry. Cell pellets from mouse IP washes were stained with 
Ly6G-PE and cd11b-APC antibodies (BioLegend) at a dilution of 1:250. 
Flow cytometry was performed on a FACS Canto II (BD) followed by analy-
sis using FlowJo software (Tree Star).
IP. 293T cells were transfected with cesium chloride purified preparations 
DNA plasmids by PEI as previously described (Inn et al., 2011). Cell lysates 
were collected 24 h after transfection in linear ubiquitination IP buffer 
(LUIP: 5M Urea, 135 mM NaCl, 1% Triton X-100, 1.5 mM MgCl2, 2 mM 
N-ethyl maleimide, and complete protease inhibitor cocktail [Roche]). For 
BMDM experiments, cells were thawed in non-TC–treated dishes and cul-
tured for 7 d in the presence of 10% L929. Cells were plated on TC-coated 
10-cm dishes on day 4 after thawing and one dish was used per condition. 
Cell lysates were collected in IP buffer (1% NP-40, 50 mM Tris, pH 7.4, 
150 mM NaCl, 0.5% sodium deoxycholate, and complete protease inhibitor 
cocktail [Roche]) and sonicated for 20 s at 10%. Lysates were precleared and 
incubated with antibody overnight at 4°C (IP) or room temperature (LUIP). 
(lethargy or shivering) even though they had considerably 
more weight loss as WT mice (Fig. 8 b), which suggests that 
perhaps these two sets of symptoms have independent mech-
anisms, with lethargy and fever caused by HOIL-1L–dependent 
inflammation and weight loss being due to an as yet unidenti-
fied factor. The HOIL-1L–dependent assembly of the NLRP3 
inflammasome and linear ubiquitination of ASC likely 
contribute to the resistance of the HOIL-1L/ mice upon 
LPS challenge because mice lacking functional NLRP3 in-
flammasomes or ASC are also resistant to LPS challenge 
(Mariathasan et al., 2004, 2006). Furthermore, the MDP- 
induced peritonitis model confirmed that HOIL-1L is indeed 
important for NLRP3 inflammasome activation in vivo 
(Fig. 7). Altogether, our data indicates that the regulation of 
inflammasome activation is achieved through complex ubiq-
uitin linkage codes that in turn may have distinct conse-
quences in response to stimuli. Our work has identified new 
members of a growing network of ubiquitin-mediated regu-
lation, which is an increasingly appreciated mechanism for 
PRR signaling pathways.
MATERIALS AND METHODS
Mice. WT C57BL/6 mice were purchased from Charles River. HOIL-
1L/ mice have been previously described and were bred as homozygotes 
(Inn et al., 2011). For BMDM isolation, 6–8-wk-old male mice were sacri-
ficed and BM cells were frozen as previously described (Marim et al., 2010). 
For MDP experiments, 7–10-wk-old female age-matched mice were in-
jected in the i.p. cavity with 1 mg MDP (Sigma-Aldrich) in 100 µl PBS. 5 h 
after injection, a 1-ml PBS wash of the i.p. cavity was collected. Cells were 
pelleted from this wash for flow cytometry and supernatants were probed for 
cytokines by ELISA. For sepsis experiments, 6–14-wk-old age-matched and 
sex-matched mice were injected in the i.p. cavity with 30 mg/kg ultrapure 
LPS (Escherichia coli 0111:B4; Sigma-Aldrich) suspended in PBS and animals 
were monitored twice daily. Mice were given DietGel 76A supplemental liq-
uid food at the beginning of weight loss. Mice were euthanized if they did 
not respond, were immobile, or lost >25% body mass. Survivors were eutha-
nized 1 wk after the i.p. injection. For serum cytokine and spleen collection, 
animals were euthanized 24 h after i.p. injection. All animal protocols were 
performed in accordance with the approval of the USC Institutional Animal 
Care and Use Committee.
BMDM cell culture, lentivirus infection, and stimulation. BM cells 
were thawed and plated at a density of 106/well of a 24-well plate in DMEM 
supplemented with 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 
and 10% L929 culture supernatant. Cells were differentiated for 1 wk with a 
media change on day 4. For IP experiments, BMDMs were trypsinized and 
plated on 10-cm dishes on day 4 after thawing. Priming with 5 µg/ml LPS 
(E. coli 0127:B8; Sigma-Aldrich) was done overnight in fresh media on day 
6 after thawing for all experiments. Stimulation with 10 µg/ml MDP (N-
Acetylmuramyl-l-alanyl-d-isoflutamine hydrate; Sigma-Aldrich) was done 
for 1 h in DMEM followed by a 30-min pulse with 5 mM ATP (Sigma- 
Aldrich). Stimulation with 10 µM Nigericin (Sigma-Aldrich) was done for 4 h 
(for caspase-1 cleavage and IL-1 secretion experiments) or 2 h (for IP and 
ASC foci experiments) in DMEM after overnight priming with 5 µg/ml 
LPS. Stimulation with 200 µg/ml silica or MSU (InvivoGen) was done dur-
ing the last 8 h of the 11-h priming with LPS treatment. Stimulation with 
dsDNA was done for 4 h after LPS priming by Lipofectamine 2000 (Life 
Technologies)–mediated transfection with pEGFP-N1 (Takara Bio Inc.) 
vector DNA at a ratio of 1.5 µg DNA to 2 µl lipofectamine per well of a 24-
well plate. Cells were stimulated with flagellin by infection at MOI 300 with 
Ad5-Flagellin or Ad5 control adenoviruses for 24 h after LPS priming. Cells 
were stimulated with L. pneumophila at MOI 1 or 10 for 2 h. Adenoviruses 
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GST-CoZi pulldown. The CoZi domain of human Nemo (Lee et al., 2012) 
was cloned into the BamHI and XhoI sites of the pGEX-6P-1 vector and the 
R309A, R312A, E313A triple mutant was generated through standard serial 
PCR with mutant oligos. BL21 bacteria were transformed with WT and rre 
Cozi pGEX plasmids and protein expression was induced with 0.3 mM IPTG 
when cells reached OD600 0.5. After 90 min, cells were pelleted and lysed in 
HEPES-CHAPS buffer (20 mM Hepes, pH 8.0, 200 mM NaCl, and 15 mM 
CHAPS) supplemented with a complete protease inhibitor cocktail (Roche). 
After sonication and removal of the pellet, lysates were precleared for 1 h with 
Sepharose beads (GE Healthcare) and then incubated with GST4b beads (GE 
Healthcare) for 2 h at 4°C. Beads were washed extensively in Hepes-CHAPS 
buffer and then IP buffer. In parallel, lysates from 293T cells transfected with 
pIRES-ASC-3xFlag, pCDNA3.1-HOIL-1L-HA, and pCDNA3.1-Myc-
HOIP plasmids (or empty vector controls) as indicated were collected in IP 
buffer supplemented with complete protease inhibitor cocktail (Roche) and 
2 mM N-ethylmaleimide (NEM; Sigma-Aldrich) and precleared for 1 h with 
GST4b beads (GE Healthcare). Finally, 293T lysates were incubated with WT 
or rre Cozi GST beads overnight at 4°C. Beads were washed in IP buffer and 
boiled in 2× Laemmli dye for Western blotting.
In vitro linear ubiquitination assay. ASC-Flag and NLRP3-Flag were 
purified from 293T cells by M2 beads (Sigma-Aldrich) in high salt buffer 
(500 mM NaCl, 1% NP-40, and 50 mM Tris, pH 8.0) and eluted with Flag 
peptide (Sigma-Aldrich), followed by 10 kD MWCO dialysis in excess TBS 
overnight. HOIL-1L-6xHIS and HOIP-6xHIS were cloned into the pET-
duet-1 vector, coexpressed in BL21 DE3 RIPL (Agilent Technologies) bacte-
ria, and purified from cultures grown in the presence of 0.2 mM ZnCl2 and 
0.5 mM IPTG at 16°C for 24 h. Cells were lysed in native buffer (50 mM Tris, 
PH 8.0, and 100 mM NaCl) and HOIL-1L/HOIP were co-purified on cobalt 
beads (Thermo Fisher Scientific) with 150 mM imidazole elution and over-
night dialysis in lysis buffer. HOIL-1L/HOIP (LUBAC) purification preps 
were stored at 4°C and never frozen. E1 (Ube1), E2 (UbcH5c), and ubiquitin 
were purchased from Boston Biochem. In vitro linear ubiquitination assays 
contained 200 ng E1, 400 ng E2, 1 µg HOIL-1L/HOIP-6xHIS purification 
prep, 20 mM Tris, pH 7.5, 5 mM DTT, 5 mM MgCl2, 2 mM MgATP (Boston 
Biochem), 10 µg ubiquitin, and 0.5 µg purified Flag-tagged substrate.
Deubiquitinase assay. Beads from one linear ubiquitin IP from 293T cells 
expressing HOIL-1L-HA, myc-HOIP, and ASC-V5 were split into three 
tubes that were treated with reaction buffer (20 mM Hepes, pH 8.0, 50 mM 
NaCl, 1 mM MgCl2, and 5 mM -mercaptoethanol), 0.8 µM Otulin (Boston 
Biochem), or 0.04 mg/ml AMSH (Boston Biochem) at 30°C for 1 h in a 
total volume of 25 µl. Samples were diluted to 1× LDS loading dye (Life 
Technologies) and analyzed by Western blotting.
Statistical analysis. All experiments were performed three times and a rep-
resentative experiment is presented here, except for BMDM IPs, which were 
performed on lysates combined from several mice in two separate experi-
ments. For experiments with statistical analysis, a two-tailed Student’s t test 
and p-values of <0.05 were considered significant.
Online supplemental material. Table S1 lists transcripts with a lower 
abundance in HOIL-1L/ BMDMs and Table S2 lists transcripts with a 
higher abundance in HOIL-1L/ BMDMs. Table S3 lists the primers used 
for qPCR. Fig. S1 shows immunoblot and IP controls for the linear ubiquitin 
antibody. Video 1 shows the Z-stacks for Fig. 4 c. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20132486/DC1.
We thank Drs. Vishva Dixit (Genentech), Junying Yuan (Harvard Medical School), 
Si-Yi Chen (University of Southern California), Feng Shao (National Institute of 
Biological Sciences, Beijing, China), and Blossom Damania (University of North 
Carolina at Chapel Hill) for reagents. We thank the USC Norris Comprehensive 
Cancer Center Beckman Center for Immune Monitoring for running the multiplex 
cytokine assay. We thank the USC Pathology Immunohistochemistry core for 
spleen sectioning and staining. We thank the Cell and Tissue Imaging Core of USC 
Research Center for Liver Diseases for providing microscopy services (National 
For LUIP, 0.25 µg of antibody was used (Genentech) per 10-cm dish of cells. 
For BMDM IPs, 2 µg rabbit antibody was used for ASC (Santa Cruz Bio-
technology, Inc.). Protein A/G beads were incubated with lysate/antibody 
mixtures for 2 h before washing 3 times in IP buffer or 2 times in LUIP buf-
fer followed by 2 PBS washes. IP beads were boiled in 2× Laemmli dye for 
10 min and LUIP beads were incubated at 70°C for 10 min in LDS dye (In-
vitrogen) supplemented with fresh 5 mM DTT to elute protein complexes 
for Western blotting.
Immunoblotting. Cell lysates were collected in RIPA buffer (IP buffer + 
0.1% SDS) and quantified by Bradford protein assay (Thermo Fisher Scien-
tific). Proteins were separated by SDS-PAGE and transferred to PVDF mem-
brane (Bio-Rad Laboratories) by semi-dry transfer at 25V for 30 min. For 
linear ubiquitin Western blots, SDS-PAGE was transferred to nitrocellulose 
(Bio-Rad Laboratories) by wet transfer at 4°C for 2 h at 30V. All membranes 
were blocked in 5% milk in PBST and probed overnight with indicated anti-
bodies in 3% BSA, except for the linear ubiquitin antibody, which was incu-
bated at room temperature for 1 h. Primary antibodies included: mouse IB 
(1:1,000; Cell Signaling Technology), mouse IL-1 (1:1,000; R&D), mouse 
caspase-1 (Santa Cruz Biotechnology, Inc.), actin (clone C4; Santa Cruz Bio-
technology, Inc.), ASC (1:1,000; Santa Cruz Biotechnology, Inc.), human 
HOIP (1:250; Acris), V5 (1:2,000; Life Technologies), Flag (1:2,000; Sigma-
Aldrich), and HA (1:2,000; Covance). Antibodies against HOIL-1L have been 
previously described (Tokunaga and Iwai, 2009). The linear ubiquitin anti-
body was a gift from Genentech and has been previously characterized in de-
tail (Matsumoto et al., 2012). In brief, samples for linear ubiquitin immunoblots 
were separated by SDS-PAGE and transferred to nitrocellulose by wet transfer 
at 4°C, 30 V, for 2 h. Membranes were blocked in 5% milk in PBST, probed with 
primary antibody (1:2,000) for 1 h at room temperature, washed, probed 
with TrueBlot-HRP (1:300; Thermo Fisher Scientific), and then developed 
with ECL (Thermo Fisher Scientific). For all other antibodies, appropriate 
HRP-conjugated secondary antibodies were incubated on membranes and 
bands were developed with ECL reagent (Thermo Fisher Scientific) and im-
aged on an LAS-4000 imager (Fuji). For IP with Western blots, the Clean 
Blot HRP secondary (1:300; Thermo Fisher Scientific) was substituted.
Immunofluorescence. FAM-YVAD-FLICA (FLICA; ImmunoChemistry 
Technologies) was reconstituted and diluted according to the manufacturer’s 
instructions. FLICA was added to cells in DMEM containing 10 µg/µl MDP 
and 10% L929. 300 µl of this solution was added per well of a 24-well plate 
containing BMDM. After 2 h, ATP was added to the media at a concentra-
tion of 2.5 mM. 30 min later, the supernatant was removed and the cells were 
washed three times with PBS. The fixative provided by the manufacturer was 
added to the cells for 15 min at room temperature. For antibody staining, cells 
were fixed with methanol, washed three times, and permeabilized with 0.1% 
Triton X-100 for 10 min at room temperature. Blocking buffer (3% BSA in 
PBS) was applied for 1 h. Cells were incubated with anti–Caspase-1 (1:100; 
Santa Cruz Biotechnology, Inc.), anti-linear ubiquitin (1F11/3F5/Y102L, 
1 µg/ml; Genentech), anti-ASC (AL177, 1:100; Enzo), and/or anti-HA (MMS-
101P, 1:500; Covance) for 1 h. Cells were washed three times in PBS and in-
cubated with Alexa Fluor–coupled secondary antibodies (1:500; Invitrogen) 
for 1 h. Cells were washed three times in PBS and incubated with Hoechst 
stain (1:1,000; Molecular Probes) for 10 min. Cells were mounted in Pro-
Long Gold Antifade media and imaged with a confocal microscope (LSM510; 
Carl Zeiss) equipped with an EC Plan-Apochromat 63×/1.4 oil objective or 
a Plan-Apochromat 100×/1.4 oil DIC objective. Images were processed 
using LSM 510 Version 4.2 SP1 acquisition software. Z-stack images were 
taken with a Plan-Apochromat 100×/1.4 oil DIC objective.
Immunohistochemistry. Spleens were fixed in 10% formalin and embedded 
in paraffin. Sectioning, hematoxylin, eosin, and Annexin V (1:50; Novus Bio-
logicals) staining were performed by the USC Immunohistochemistry Core 
facility. Images were acquired on a microscope (IX71; Olympus) using the 10× 
(Plan C 10×/0.25 PhC; Olympus) and 40× (SLC Plan F1 40×/0.55 Ph2; 
Olympus) objectives as indicated with a Digital Sight DS-Fi1 camera (Nikon).
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